Massonnaud CR, Peiffer-Smadja N, Poignard P, Jamard S, Goehringer F, Danion F, Reignier J, de Castro N, Garot D, Lapique EL, Lacombe K, Tolsma V, Faure E, Malvy D, Staub T, Courjon J, Cazenave-Roblot F, Dyrhol Riise AM, Leturnier P, Martin-Blondel G, Roger C, Akinosoglou K, Vincent Le Moing, Piroth L, Sellier P et al. (2025)
Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in hospitalized COVID-19 patients: long-term results from the DisCoVeRy trial
Clin Microbiol Infect (in press)
DOI 10.1016/j.cmi.2025.12.014, PubMed 41429349

Sester M, Altet-Gomez N, Andersen ÅB, Arias-Guillén M, Avsar K, Bakken Kran AM, Bothamley G, Nordholm Breschel AC, Brown J, Chesov D, Ciobanu N, Cirillo DM, Crudu V, de Souza Galvao M, Dilektasli AG, Dominguez J, Duarte R, Dyrhol-Riise AM, Goletti D, Hoffmann H, Ibraim E, Kalsdorf B, Krawczyk M, Kunst H, Lange B et al. (2025)
Correction to Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study Lancet Reg Health Eur 57 (2025) 101416 LLRHEUROPE-D-25-00310
Lancet Reg Health Eur, 59, 101523
DOI 10.1016/j.lanepe.2025.101523, PubMed 41399688

Ghorbani M, Kvedaraite A, Al-Manei K, Too CB, Cederberg S, Johannessen A, Reikvam DH, Valentini D, Maucourant C, Björkström NK, Aleman S, Sällberg Chen M (2025)
Oral Microbiome Diversity Matters on Nucleos(t)ide Analogue Cessation in Chronic Hepatitis B
J Infect Dis (in press)
DOI 10.1093/infdis/jiaf591, PubMed 41328917